Operating
Moderna·Cash Flow Statement·21 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net income | -$1.3B | $13M | -$1.1B | -$971M | -$825M | -$200M | -$826M | -$1.3B |
| Net cash from operating activities | -$1.3B | -$1.6B | — | -$1B | -$919M | -$847M | — | -$630M |
| Change in accrued liabilities | -$66M | — | — | -$381M | -$14M | — | — | $464M |
| Change in accounts payable | — | — | — | -$156M | -$47M | — | — | -$120M |
| Change in accounts receivable | $0 | $1.4B | -$1.2B | -$280M | -$30M | $1B | -$859M | -$114M |
| Stock-based compensation | $112M | $112M | $104M | $115M | $130M | $125M | $113M | $104M |
| Depreciation and amortization | $41M | $52M | $60M | $39M | $57M | $52M | $67M | $59M |
| Depreciation and amortization | $41M | $52M | $60M | $39M | $57M | $52M | $67M | $59M |
| Change in other assets | $0 | $150M | -$292M | -$46M | $196M | -$66M | -$237M | -$54M |
| Increase (Decrease) in Prepaid Expense and Other Assets | $0 | $150M | -$292M | -$46M | $196M | -$66M | -$237M | -$54M |
| Change in other liabilities | -$186M | $4M | $141M | $33M | -$58M | -$112M | — | $26M |
| Increase (Decrease) In Right Of Use Asset, Operating Leases | $78M | $1M | — | -$9M | -$10M | -$9M | -$10M | -$11M |
| Investment Income Net Amortization Of Discount And Premium | $28M | $21M | $19M | $19M | $18M | $17M | $13M | $11M |
| Change in operating lease liabilities | $31M | $8M | — | -$5M | -$5M | -$5M | -$6M | -$7M |
| Operating lease liabilities | $31M | $8M | — | -$5M | -$5M | -$5M | -$6M | -$7M |
| Change in inventories | $104M | $11M | -$291M | $8M | $114M | $91M | — | -$6M |
| Other working capital changes | -$4M | $0 | -$54M | -$2M | -$34M | -$14M | -$27M | -$6M |
| Other Noncash Income (Expense) | -$4M | $0 | -$54M | -$2M | -$34M | -$14M | -$27M | -$6M |
| Change in deferred revenue | $179M | -$323M | -$262M | -$29M | $97M | $40M | — | $5M |
| Distributions from equity method investments | -$22M | -$8M | -$9M | -$8M | — | — | -$3M | -$2M |
| Income Loss From Equity Method Investments Net Of Dividends Or Distributions | -$22M | -$8M | -$9M | -$8M | — | — | -$3M | -$2M |